Pediatric intrathecal baclofen management during the COVID-19 pandemic in the US and Canada

J Pediatr Rehabil Med. 2020;13(3):379-384. doi: 10.3233/PRM-200755.

Abstract

The COVID-19 pandemic has been a challenge to healthcare systems around the world. Within pediatric rehabilitation medicine, management of intrathecal baclofen has been particularly challenging. This editorial reviews how programs in the US and Canada coped with the quickly changing healthcare environment and how we can learn from this pandemic to be prepared for future crises.

Keywords: COVID-19; Intrathecal baclofen; pump; risk of exposure.

Publication types

  • Letter

MeSH terms

  • Baclofen / administration & dosage*
  • COVID-19 / epidemiology*
  • Child
  • Comorbidity
  • Humans
  • Injections, Spinal
  • Muscle Relaxants, Central / administration & dosage
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / epidemiology
  • Pandemics*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Muscle Relaxants, Central
  • Baclofen